At ASHG, Seer showcased its Proteograph product suite which it claims delivers proteomic insights that complement and ...

A trio of stock analysts this week examined the likely impacts on biopharma from Donald Trump’s election victory and ...

The most important takeaway from the study is that these data suggest that CD47 is an attractive target for drug development.

Researchers say new research findings might point to a major opportunity to act sooner to prevent rheumatoid arthritis.

Researchers say study offers proof-of-concept that targeting how T cells interact with metabolites in their environment can ...

Julianna LeMieux and Uduak Thomas discuss their time at the ASHG meeting in Denver and some of the trends that they are ...

ProBioGen’s AGE1.CR.PIX been developed as a stable proliferating avian cell line that is highly permissive for different ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

Lonza has continued to adapt to the evolving ADC landscape, including the recent addition of a highly potent vial fill ...

New research demonstrates how a chemical produced by a caterpillar fungus shows promise as a possible cancer treatment by ...

ASHG 2024 professional awardees include two awardees in the lifetime achievement category and one awardee each in the ...

After dosing with Cognition’s CT1812, study reports declines of 95% and higher in subgroup with below-median p-tau217.